Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.
Whitehill, Greg D
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy 09 2016 - 1655-64 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1525-0024
10.1038/mt.2016.147 doi
Adenosine--pharmacology
Adult
Aged
Aged, 80 and over
Antigens, Neoplasm
Cell Survival--drug effects
Graft vs Host Disease--etiology
Haplotypes
Humans
Immunity
Leukemia--complications
Lymphocyte Depletion
Lymphocyte Subsets--drug effects
Middle Aged
T-Cell Antigen Receptor Specificity--immunology
T-Lymphocytes--drug effects
Tissue Donors
Viruses--immunology
Young Adult
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy 09 2016 - 1655-64 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1525-0024
10.1038/mt.2016.147 doi
Adenosine--pharmacology
Adult
Aged
Aged, 80 and over
Antigens, Neoplasm
Cell Survival--drug effects
Graft vs Host Disease--etiology
Haplotypes
Humans
Immunity
Leukemia--complications
Lymphocyte Depletion
Lymphocyte Subsets--drug effects
Middle Aged
T-Cell Antigen Receptor Specificity--immunology
T-Lymphocytes--drug effects
Tissue Donors
Viruses--immunology
Young Adult